Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Inmune Bio (INMB) Other Operating Expenses (2019 - 2025)

Historic Other Operating Expenses for Inmune Bio (INMB) over the last 6 years, with Q2 2025 value amounting to $16.5 million.

  • Inmune Bio's Other Operating Expenses rose 1377731.09% to $16.5 million in Q2 2025 from the same period last year, while for Sep 2025 it was $16.5 million, marking a year-over-year increase of 1477747.75%. This contributed to the annual value of -$1.3 million for FY2022, which is 1356.36% down from last year.
  • Per Inmune Bio's latest filing, its Other Operating Expenses stood at $16.5 million for Q2 2025, which was up 1377731.09% from $119000.0 recorded in Q2 2024.
  • In the past 5 years, Inmune Bio's Other Operating Expenses ranged from a high of $16.5 million in Q2 2025 and a low of -$425000.0 during Q1 2022
  • Its 5-year average for Other Operating Expenses is $2.3 million, with a median of -$8000.0 in 2021.
  • Per our database at Business Quant, Inmune Bio's Other Operating Expenses crashed by 521250.0% in 2022 and then skyrocketed by 1377731.09% in 2025.
  • Quarter analysis of 5 years shows Inmune Bio's Other Operating Expenses stood at -$8000.0 in 2021, then crashed by 5212.5% to -$425000.0 in 2022, then soared by 78.82% to -$90000.0 in 2023, then surged by 232.22% to $119000.0 in 2024, then soared by 13777.31% to $16.5 million in 2025.
  • Its last three reported values are $16.5 million in Q2 2025, $119000.0 for Q2 2024, and -$8000.0 during Q1 2024.